“A Clinical Review of Noninvasive Tests for Hepatic Fibrosis” by Nikita Chadha, DO, and Richard K. Sterling, MD, MSc gastroenterologyandhepatology.net/archives/june-… Nikita Chadha, D.O. VCU Health

🚩 Replay today's LIVE discussion re: strategies to support the implementation of current recommendations for hepatitis B vaccination.

Join the VCU team in walking the walk. FREE registration ends Aug. 28.

NEW in Gut Microbes: @jasmohanbajaJ and colleagues report on Gut microbiome profiles to exclude the diagnosis of hepatic encephalopathy in patients with cirrhosis. Of course, it involves 💩 bit.ly/4dYvf8a #livertwitter

In Digestive Diseases and Sciences, our team reports Lille score has good sensitivity in predicting 30-day survival in those w/AH treated w/steroids, but poor specificity. Need to determine best method to clarify survival. #Livertwitter bit.ly/3YYEb96 Richard Sterling Joel P Wedd MD, MPH

ICYMI! Participate in the first ALF #Liver Life Walk here in Richmond on Sat., Oct. 12. Donate or sign up to walk with team “UnStoppable VCU Liver” at liverlifewalk.org/virginia/ #LiverLifeWalk #UnStoppableVCULiver #LiverTwitter VCU Stravitz-Sanyal Institute for Liver Disease American Liver Foundation National

Medicaid connects many Americans to #HealthInsurance, improving access to #HepatitisC treatment. Read how the expansion of #Medicaid can support #HepC elimination by removing barriers to treatment: bit.ly/3zVGI9u

NEW: HHS.gov released the 2023 Viral Hepatitis Progress Report, using 2021 data to track progress towards #ViralHepatitis elimination. Explore how the US is performing against 5 key goals (including 8 core indicators & 8 disparity measures) via the report: bit.ly/3XnQJWs

Research Administrator Day Sept. 26 🎉 Join the VCU RAs in the Cabell Library, Room 303 on Sept. 26, 2024 to celebrate the Research Admin profession with a full day of informative presentations, fun activities, awards & networking opportunities. Register: bit.ly/47lTXgE

More on HE from our Jasmohan Bajaj.

Are all #infections in #cirrhosis equal worldwide? No! Striking regional variations due to culture resources & antibiotic overuse ✅The Lancet Gastroenterology & Hepatology from CLEAREDConsortium w >4000 pts⤵️ authors.elsevier.com/a/1jj7R8nByrCi… Join▶️clearedconsortium.org 💯comment Salvatore Piano Dr Nipun Verma

Liver news from The Lancet today. Saul Karpen

It's #PBC awareness month... tune into my 6-part series with HCPLive on PBC Management: hcplive.com/view/recent-ad…

From ReachMD: Researching the Overlap: Hepatic Encephalopathy and Dementia in Focus. Listen to the conversation with Jasmohan Bajaj. bit.ly/3XuMCI4 #HE #livertwitter

Lots of excellent #liver research in The Lancet today. Here's one from Jasmohan Bajaj.

Our paper analyzing #MASLD #liver biopsies from people with #HIV is out! Case-control with non-HIV MASLD: More fibrosis for less activity. Daniela Allende, MD MBA Naga Chalasani Rohit Loomba onlinelibrary.wiley.com/doi/10.1111/ap…

You think you know secondary SBP prophylaxis, and then a paper from Jasmohan Bajaj, Richard Sterling & #VCU colleagues in AJG - The American Journal of Gastroenterology found that in patients with SBP, SecSBPPr actually ⤴️⤴️ risk of recurrence. #livertwitter #twdfnr bit.ly/3ZcnFSY

Less=More w #antibiotics in #cirrhosis & ✅ reconsider #SecSBPProphylaxis AJG - The American Journal of Gastroenterology⤵️ pubmed.ncbi.nlm.nih.gov/39235290/ 🔑#SecSBPPr vs others▶️⬆️SBP recurrence &🚫mortality benefit 🔑2 datasets (VA Research & TriNetX) w similar trends 🔑worsens over time & validated locally Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟

Too busy wrapping up the week for a deep read? Check out our blog on the most recent Jasmohan Bajaj paper, from the CLEARED Consortium, in The Lancet. #livertwitter bit.ly/4gd12nw

At Paris MASH Meeting, hepatologists from our institute are sharing knowledge garnered from the latest liver research and best practices on bringing the best treatments to #MASH and #MASLD patients. #livertwitter paris-mash.org for more details. Arun J. Sanyal Saul Karpen